Latest / Injectable & Ophthalmic Insights / What to Actually Ask a Third Party Injection Manufacturer Before You Sign
Transcript
- 0:00Speaker 1: You know, usually when you walk into a doctor's office
- 0:03Speaker 1: or a clinic and the nurse comes in holding a syringe,
- 0:08Speaker 1: there's this implicit, almost invisible expectation of absolute perfection.
- 0:13Speaker 2: Oh, absolutely total trust.
- 0:16Speaker 1: Right, you don't look at that little glass vial of
- 0:19Speaker 1: clear liquid and wonder, you know if the air conditioning
- 0:21Speaker 1: was working properly in the factory where it was bottled.
- 0:24Speaker 2: No, you definitely don't.
- 0:25Speaker 1: You don't question the microbial account of the room it
- 0:27Speaker 1: was sealed in. You just assume the engineering behind it
- 0:30Speaker 1: is flawless, Like the medicine is either perfectly safe or
- 0:33Speaker 1: it wouldn't be in the room with you.
- 0:35Speaker 2: Yeah, we rely heavily on that comfort. I mean, we
- 0:37Speaker 2: really like things to be binary when it comes to
- 0:39Speaker 2: our health, safe or unsafe. But behind that tiny glass
- 0:44Speaker 2: vial is an incredibly unforgiving global supply chain.
- 0:48Speaker 1: Unforgiving is the right way.
- 0:49Speaker 2: It really is. It's a high stakes, zero margin for
- 0:52Speaker 2: error environment where just you know, one microscopic mistake can
- 0:56Speaker 2: have disastrous physiological consequences.
- 0:59Speaker 1: And navigating that environment is daunting, which brings us to today. Today,
- 1:04Speaker 1: we're doing a deep dive into a fascinating, incredibly dense
- 1:07Speaker 1: excerpt from an industry insider show called Injectable and Ophthalmic Insights.
- 1:13Speaker 2: It's a great source, really detailed.
- 1:15Speaker 1: Super detailed, and our mission today is decoding the ultimate
- 1:19Speaker 1: uncompromising checklist for farmer brands that are looking to partner
- 1:23Speaker 1: with a third party injection manufacturer in India. So, okay,
- 1:27Speaker 1: let's unpack this because if you want to understand how
- 1:29Speaker 1: this invisible vetting process works, we have to start with
- 1:32Speaker 1: the most common catastrophic mistake brands make on day one.
- 1:36Speaker 1: They sit down at the negotiating table and they prioritize
- 1:39Speaker 1: the wrong thing entirely.
- 1:40Speaker 2: Oh yeah, they fall right into the price trap.
- 1:42Speaker 1: The price trap. The source calls us out immediately. Most
- 1:45Speaker 1: brands go into these critical conversations and the very first
- 1:49Speaker 1: question they ask is how much is this going to
- 1:50Speaker 1: cost per unit?
- 1:51Speaker 2: Which makes sense right from a.
- 1:53Speaker 1: Pure business standpoint, you get it, margins matter, But the
- 1:57Speaker 1: insider source explicitly states that price is actually the fifth
- 2:01Speaker 1: most important thing on the list. Fifth.
- 2:04Speaker 2: It's a complete paradigm shift because if cost is relegated
- 2:07Speaker 2: to number five, it forces you to look at what
- 2:10Speaker 2: actually keeps a pharmaceutical company legally and medically viable. Yeah,
- 2:14Speaker 2: the source is definitive here. Your first priority before anything
- 2:18Speaker 2: else must be certifications. But they aren't just talking about
- 2:22Speaker 2: checking a box. You know, you need to be aggressively
- 2:25Speaker 2: interrogating their who GMP and isostatic?
- 2:29Speaker 1: Yeah right, and let's break those acronyms down quickly for
- 2:32Speaker 1: anyone who you know isn't spending their weekends reading international tradelote.
- 2:36Speaker 2: Fair enough.
- 2:36Speaker 1: So GMP stands for good Manufacturing Practices and having the
- 2:41Speaker 1: WAHO World Health Organization stamp on It means a facility
- 2:45Speaker 1: is adhering to a globally recognized, incredibly strict legal framework.
- 2:50Speaker 2: Exactly.
- 2:50Speaker 1: It's not a suggestion. It dictates everything from basic hygiene
- 2:53Speaker 1: to complex equipment maintenance.
- 2:55Speaker 2: And that framework is exactly why the source insists that
- 2:58Speaker 2: simply having those acronyms on a website is basically meaningless.
- 3:01Speaker 1: Yeah, anyone can do that, right.
- 3:03Speaker 2: Anyone can hang a plaque their lobby from an audit
- 3:06Speaker 2: they passed like seven years ago. The directive here is
- 3:09Speaker 2: that you have to ask for the actual audit history,
- 3:12Speaker 2: like when was it renewed and crucially were there any
- 3:16Speaker 2: regulatory observations in their recent audits.
- 3:19Speaker 1: It's basically the ultimate car fax for a factory.
- 3:22Speaker 2: That's a great way to put it.
- 3:23Speaker 1: Yeah, you don't buy a used car by just looking
- 3:26Speaker 1: at the sticker price and admiring this shiny paint job.
- 3:29Speaker 1: You demand the accident history, the maintenance logs, the objective
- 3:34Speaker 1: reality of how that machine has been treated. Absolutely, And
- 3:37Speaker 1: what's brilliant about this source material is how it points
- 3:40Speaker 1: out that asking for the audit history triggers a behavioral tell.
- 3:44Speaker 2: It reveals the internal culture of the facility immediately, like
- 3:47Speaker 2: right there in the room.
- 3:48Speaker 1: Yes, if the manufacturer gets vague, or if they try
- 3:51Speaker 1: to deflect and say, listen, don't worry about the paperwork,
- 3:54Speaker 1: our qualities top notch. Look at this clean room, that
- 3:57Speaker 1: is a glaring red flag.
- 3:58Speaker 2: Huge red flag.
- 4:00Speaker 1: If they immediately hand over the binder with their audit history,
- 4:04Speaker 1: even if that history contains minor notes or infractions that
- 4:07Speaker 1: they've since corrected, that transparency demonstrates a profound confidence in
- 4:12Speaker 1: their own.
- 4:12Speaker 2: Compliance because regulatory observations are normal, I mean, an auditor's
- 4:16Speaker 2: job is to find something to improve. Minor notes aren't
- 4:19Speaker 2: a death sentence provided they were immediately addressed, but attempting
- 4:23Speaker 2: to hide them implies a systemic cultural rot within the organization.
- 4:27Speaker 2: If they lie about a minor paperwork infraction, what are
- 4:30Speaker 2: they going to do when a batch of medicine gets contaminated?
- 4:33Speaker 1: Exactly, But that structural rigidity on paper is great, but
- 4:38Speaker 1: paper doesn't manufacture medicine buildings do they do? Which means,
- 4:42Speaker 1: once a company proves they are culturally compliant, you have
- 4:45Speaker 1: to verify that their physical architecture actually supports their claims.
- 4:50Speaker 2: We are talking about the cleanroom infrastructure, and a cleanroom
- 4:53Speaker 2: isn't just a place where people where hair NEETs and
- 4:56Speaker 2: booties and mop the floor with.
- 4:57Speaker 1: Bleach, not even close. A pharmacy sceutical cleanroom is an
- 5:01Speaker 1: actively engineered environment. The room itself is a machine, Yes
- 5:04Speaker 1: it is. They use positive air pressure, so when you
- 5:07Speaker 1: open a door, air constantly rushes out, preventing unsterilized air
- 5:11Speaker 1: from sneaking in. The air is entirely recycled through hepathilters
- 5:16Speaker 1: every few minutes to scrub out microscopic particles.
- 5:19Speaker 2: And even with all of that incredible engineering, the source
- 5:22Speaker 2: highlights a non negotiable rule, which is separate manufacturing areas
- 5:27Speaker 2: for different product categories. They use hormonal injectibles as the
- 5:31Speaker 2: prime example. According to global regulations, hormonal injectables must be
- 5:35Speaker 2: manufactured in completely dedicated, segregated units, physically isolated from non
- 5:41Speaker 2: hormonal products.
- 5:42Speaker 1: Okay, hold on, I want to challenge the logic there
- 5:43Speaker 1: for a second. If a clean room is fundamentally designed
- 5:46Speaker 1: to scrub particles out of the air, and the staff
- 5:49Speaker 1: sterilizes the equipment between batches, why does the physical layout
- 5:53Speaker 1: matter so much? Like why can't a manufacturer run a
- 5:57Speaker 1: batch of hormones on Monday, deep clean the room on
- 5:59Speaker 1: Tuesday day, and then run saline eye drops on Wednesday.
- 6:03Speaker 2: What's fascinating here is the sheer biological potency of the
- 6:06Speaker 2: compounds we're dealing with. Hormones are biologically active at microscopic,
- 6:11Speaker 2: practically imperceptible levels. We are talking about parts per million
- 6:15Speaker 2: or even parts per billion having a massive physiological effect
- 6:19Speaker 2: on the human endocrine system.
- 6:21Speaker 1: So the standard cleaning protocols just aren't enough to guarantee safety.
- 6:24Speaker 2: It's a risk that regulatory bodies simply will not tolerate.
- 6:28Speaker 2: Think about the HVAC system, the heating and air conditioning.
- 6:32Speaker 2: If you manufacture a highly potent hormonal drug, the microscopic
- 6:38Speaker 2: dust from that process gets pulled into the air returns.
- 6:41Speaker 1: Oh wow.
- 6:41Speaker 2: Yeah. If you use that same air handling system for
- 6:44Speaker 2: a different room manufacturing a basic saline eye drop, and
- 6:48Speaker 2: even a single aerosolized particle of that hormone makes it into.
- 6:52Speaker 1: The eye drop file, that's terrifying.
- 6:54Speaker 2: The consequences for the patient using that eye drop are disastrous.
- 6:57Speaker 2: You cannot clean away a shared ventilation system. If the
- 7:01Speaker 2: manufacturer cannot instantly produce blueprints proving that their facility has distinct,
- 7:06Speaker 2: physically segregated air handling and architectural layouts, you walk away because.
- 7:10Speaker 1: An architectural flaw basically guarantees a medical flaw down the line. Okay,
- 7:14Speaker 1: so we have our transparent audit history, and we have
- 7:17Speaker 1: our perfectly segregated positive pressure clean rooms. But a perfectly
- 7:22Speaker 1: sterile room is completely useless to you if it doesn't
- 7:25Speaker 1: hold the right machinery technical mashing.
- 7:27Speaker 2: It's the next massive hurdle. Can the specific building handle
- 7:31Speaker 2: the exact chemistry of your formulation right?
- 7:34Speaker 1: And the source lists several distinct categories to illustrate how
- 7:38Speaker 1: specialized this gets. Right, You've got liquid injections, dry powder injections,
- 7:44Speaker 1: hormonal parentials, which, by the way, parential just means something
- 7:47Speaker 1: administered by bypassing the digestive tract, usually an injection. In
- 7:51Speaker 1: ophthalmic preparations, which are eye drops, right, every single one
- 7:54Speaker 1: of these requires totally different machinery.
- 7:56Speaker 2: There is this really calming misconception that pharmaceutical manift is
- 8:00Speaker 2: a singular skill set, like a factory is a factory.
- 8:04Speaker 2: But the equipment required to safely fill a liquid eye
- 8:07Speaker 2: drop is fundamentally different from the equipment required to process
- 8:10Speaker 2: a dry powder injection.
- 8:12Speaker 1: It's like assuming a brilliant sushi chef can just flawlessly
- 8:16Speaker 1: execute a five tier bait wedding cake. Huh, the kitchen
- 8:19Speaker 1: is clean, right, but the equipment and the extra chise
- 8:21Speaker 1: are totally different.
- 8:22Speaker 2: That's a perfect analogy, and the source specifically points out
- 8:25Speaker 2: liofalized products as a trap people fall into. Liofalization is
- 8:30Speaker 2: freeze drying. You can't just take a factory that bottles
- 8:33Speaker 2: liquid saline and asks them to run a freeze dried powder.
- 8:37Speaker 1: Let's get into the mechanics of why that is. Yeah,
- 8:39Speaker 1: because freeze drying sounds simple, but it's really not.
- 8:42Speaker 2: Not at all. Lyofalization isn't just letting something dry out
- 8:46Speaker 2: in a sterile room. It requires a highly complex workflow.
- 8:49Speaker 2: To ensure the drug remain stable for a long shelf life,
- 8:52Speaker 2: you have to freeze the liquid formulation, place it inside massive,
- 8:56Speaker 2: highly calibrated vacuum chambers, and then slowly apply heat.
- 9:01Speaker 1: Wow.
- 9:01Speaker 2: Yeah, you ply heat so that the frozen water sublimates,
- 9:04Speaker 2: meaning it turns directly from a solid ice into a gas,
- 9:07Speaker 2: skipping the liquid phase entirely.
- 9:09Speaker 1: It's basically weaponized freezer burn, but engineered for medical stability.
- 9:13Speaker 2: Weaponized freezer burn.
- 9:14Speaker 1: I love that, Like how food gets freezer burned when
- 9:17Speaker 1: the moisture subblemates out of it in your kitchen freezer,
- 9:20Speaker 1: But here they are doing it intentionally in a massive
- 9:22Speaker 1: vacuum chamber so that the medication powder left behind is
- 9:25Speaker 1: perfectly preserved and sterile.
- 9:27Speaker 2: That is our remarkably accurate way to picture it, and
- 9:30Speaker 2: you can see why I am manufacturer who only has
- 9:33Speaker 2: bats and liquid filling nozzles cannot suddenly pivot to operating
- 9:38Speaker 2: industrial vacuum chambers and sublimation temperature controls.
- 9:42Speaker 1: Right, totally different skill set.
- 9:43Speaker 2: You have to aggressively confirm that the manufacturer has the
- 9:46Speaker 2: exact functioning mechanical setup to execute your specific chemical formulation.
- 9:52Speaker 1: And that they have the engineers on staff who actually
- 9:55Speaker 1: know how to calibrate those.
- 9:56Speaker 2: Vacuum chambers exactly.
- 9:57Speaker 1: So let's say you get the jackpot, you find a partner,
- 10:00Speaker 1: they hand over their flawless WHOGMP audit history. They have
- 10:04Speaker 1: separate buildings with isolated HVAC systems for different drug classes.
- 10:08Speaker 1: They have the exact iophalization vacuum chambers you need the
- 10:12Speaker 1: drugs roll off the assembly line. You're ready to ship, right.
- 10:15Speaker 2: You're not ready to ship a single vial, oh Man,
- 10:17Speaker 2: because the physical product is only half the battle.
- 10:20Speaker 1: Here's where it gets really interesting. The sheer, mountainous volume
- 10:24Speaker 1: of paperwork required.
- 10:25Speaker 2: Per batch is staggering.
- 10:28Speaker 1: The machinery might have done everything perfectly, but now you
- 10:31Speaker 1: have to prove it to the global health authorities.
- 10:33Speaker 2: The source outlines what they call the mandatory paper trail.
- 10:37Speaker 2: For every single batch that rolls off the line, you
- 10:40Speaker 2: must demand a specific trinity of documents. First, the batch manufacturing.
- 10:45Speaker 1: Records, which isn't just a signed piece of paper saying
- 10:48Speaker 1: we made it. This is a minute by minute diary.
- 10:51Speaker 1: It tracks every sensor readout what was the exact temperature
- 10:55Speaker 1: of the vat at two point one four pm, which
- 10:58Speaker 1: specific technician weighed the wrong materials. How long did the
- 11:01Speaker 1: mixing phase last down to.
- 11:03Speaker 2: The second exactly? Then you need the analytical CoA, the
- 11:05Speaker 2: certificate of analysis. Okay, this is the post production laboratory proof.
- 11:09Speaker 2: Scientists take samples from the finish batch and run them
- 11:12Speaker 2: through mass spectrometry and chromatography to prove that the chemical
- 11:15Speaker 2: composition inside the vial perfectly matches what the label says.
- 11:19Speaker 1: With absolutely zero deviations.
- 11:21Speaker 2: Zero deviations are impurities.
- 11:22Speaker 1: And the third document of the trinity is the one
- 11:24Speaker 1: that really highlights the paranoia of this industry.
- 11:28Speaker 2: Environmental monitoring logs, because it's not enough to prove the
- 11:31Speaker 2: chemistry is right. You know, you have to prove the
- 11:33Speaker 2: room itself didn't contaminate the chemistry while it was being mixed.
- 11:37Speaker 1: Right. They use active air samplers and settle plates, which
- 11:40Speaker 1: are basically petri dishes left open in the clean room
- 11:43Speaker 1: to constantly monitor the invisible environment. Yes, these logs prove
- 11:48Speaker 1: that the aerosolized particle counts and the microbial counts in
- 11:51Speaker 1: the room remain below strict regulatory limits during the exact
- 11:57Speaker 1: hours your specific batch was being processed.
- 12:00Speaker 2: Connect this to the bigger picture. This specific paper trail
- 12:03Speaker 2: is the ultimate shield that protects a brand. There is
- 12:06Speaker 2: a foundational rule in heavily regulated industries. If it isn't documented,
- 12:11Speaker 2: it didn't happen.
- 12:12Speaker 1: So even if you have the most technologically advanced clean
- 12:14Speaker 1: room on Earth, and you manufacture the safest, most perfect
- 12:18Speaker 1: injection in the history of medicine, if.
- 12:19Speaker 2: An auditor knocks on your door and you cannot produce
- 12:22Speaker 2: the batch manufacturing records, the CoA, and those real time
- 12:27Speaker 2: environmental logs proving exactly how you made it, that entire
- 12:31Speaker 2: batch is legally considered adulterated. Wow, it is treated as
- 12:35Speaker 2: if it were poison, and it must be destroyed. The
- 12:38Speaker 2: paperwork is the product, just as much as the liquid
- 12:40Speaker 2: in the vial is.
- 12:41Speaker 1: The paperwork is the product. That is a wild but
- 12:45Speaker 1: totally necessary way to look at it. So you look
- 12:48Speaker 1: at this gauntlet of a checklist, the pristine audit history,
- 12:51Speaker 1: the architectural segregation of HVC systems, perfectly matched specialized machinery,
- 12:57Speaker 1: and a mountain of flawless real time documentary. Yeah, it
- 13:01Speaker 1: begs the question does a facility actually exist that can
- 13:04Speaker 1: operate at this level? Or is this just theoretical best practice?
- 13:07Speaker 2: The source doesn't just leave us with theory. They provide
- 13:10Speaker 2: a benchmark case study a manufacturer called pushcar Pharma as
- 13:13Speaker 2: a real world example of how these rigorous standards are
- 13:16Speaker 2: practically applied.
- 13:17Speaker 1: Yeah, and when you look at the stats the source
- 13:19Speaker 1: provides for pushcar Pharma, they suddenly make a lot more
- 13:21Speaker 1: sense in the context of everything we've just discussed. For example,
- 13:24Speaker 1: they've been operating since nineteen ninety.
- 13:25Speaker 2: Three, which means they haven't just passed one audit, right,
- 13:29Speaker 2: they have survived three decades of continuous regulatory scrutiny.
- 13:33Speaker 1: That's huge.
- 13:34Speaker 2: It speaks directly to that culture of transparency and compliance
- 13:37Speaker 2: we talked about at the very beginning.
- 13:39Speaker 1: And then the Source mentions they have a massive seven
- 13:41Speaker 1: thousand square yard who GMP and ISO certified facility located
- 13:47Speaker 1: in cala Am. Before we break this down, seven thousand
- 13:51Speaker 1: square yards just sounded like corporate brochure speak, But now
- 13:54Speaker 1: we know why that physical footprint matters so much.
- 13:57Speaker 2: Precisely, you cannot achieve true architect segregation in a small building.
- 14:02Speaker 2: That massive space allows them to maintain dedicated, completely separated
- 14:06Speaker 2: manufacturing areas for distinct categories. They have isolated setups for
- 14:10Speaker 2: parental injections, hormonal treatments, optamic eye drops, and nasal sprays.
- 14:15Speaker 2: They have the physical space to run separate air handling
- 14:18Speaker 2: units so that a hormonal powder never crosses paths with
- 14:21Speaker 2: a sterile eye drop.
- 14:22Speaker 1: The space allows for the safety exactly. The source also
- 14:25Speaker 1: notes that they utilize aseptic automated filling for their.
- 14:28Speaker 2: Lines, which is the gold standard for reducing contamination even
- 14:32Speaker 2: in a clean room. The biggest threat to sterility is
- 14:35Speaker 2: the human being.
- 14:36Speaker 1: They're messy.
- 14:37Speaker 2: We really are. We breathe, we shed skin cells. By
- 14:41Speaker 2: automating the filling process in an aseptic environment, you remove
- 14:45Speaker 2: the human element from the most vulnerable moment when the
- 14:47Speaker 2: liquid actually enters the open vial.
- 14:50Speaker 1: It's the perfect synthesis of the entire deep dive. You
- 14:53Speaker 1: have longevity, proving cultural compliance, massive square footage allowing for
- 14:57Speaker 1: architectural segregation, automated machinery matching the exact technical needs of
- 15:02Speaker 1: the formulation, and they provide that total batch documentation transparency
- 15:07Speaker 1: on every order.
- 15:08Speaker 2: It completely validates the checklist. It proves that demanding this
- 15:11Speaker 2: level of perfection isn't impossible. It's just the baseline requirement
- 15:15Speaker 2: for keeping patients safe.
- 15:16Speaker 1: So what does this all mean. Look, even if you
- 15:19Speaker 1: listening right now, aren't a pharma executive preparing to negotiate
- 15:22Speaker 1: a massive manufacturing contract in India? This checklist is a
- 15:26Speaker 1: window into a world we all blindly rely on.
- 15:28Speaker 2: It really is.
- 15:29Speaker 1: It reveals this incredible, invisible layer of rigorous vetting, the
- 15:34Speaker 1: physical distance between air vents, the vacuum chambers, sublimating ice
- 15:38Speaker 1: into gas, the petree dishes monitoring the air minute by minute.
- 15:43Speaker 1: The peace of mind you feel when that syringe comes
- 15:45Speaker 1: out at the doctor's office. It is bought and paid
- 15:48Speaker 1: for by the paranoia of this exact checklist.
- 15:51Speaker 2: This raises an important question, though, about the sheer scale
- 15:54Speaker 2: of the information we've just unpacked, because if we look
- 15:56Speaker 2: closely at the source material, everything we've discussed today, the layout,
- 16:00Speaker 2: the audits, the paperwork, is just the prerequisite phase.
- 16:03Speaker 1: Yes, that was the tiny, easily missed detail from the
- 16:07Speaker 1: excerpt that absolutely floored me. The speaker mentioned at the
- 16:10Speaker 1: very top that this was episode seven of their show, right,
- 16:14Speaker 1: and they casually noted that they had spent the previous
- 16:16Speaker 1: several episodes covering just the manufacturing process side.
- 16:19Speaker 2: We have spent this entire time just discussing how to
- 16:22Speaker 2: vet the building and the paperwork exactly.
- 16:25Speaker 1: So here is the provocative thought to leave you with.
- 16:28Speaker 1: If simply asking these basic vetting questions, is this rigorous, strict,
- 16:33Speaker 1: and complex. Imagine the sheer mind boggling depth of the
- 16:37Speaker 1: actual step by step manufacturing process itself.
- 16:40Speaker 2: It's dizzy ing.
- 16:41Speaker 1: Think about the microscopic complexity of the chemistry, the fluid dynamics,
- 16:45Speaker 1: and the molecular biology that is hidden inside every single
- 16:48Speaker 1: tiny class vial long before the vetting even begins.
- 16:52Speaker 2: The precision required is almost unfathomable.
- 16:54Speaker 1: It truly is. Next time you see a tiny medical vial,
- 16:57Speaker 1: you're going to see a mountain of invisible engineering behind it.
- 17:00Speaker 1: Thanks for joining us on this journey behind the curtain.
- 17:02Speaker 1: Keep questioning the invisible systems around you, and stay curious
- 17:05Speaker 1: until our next deep dive